And as others have mentioned, the only data for the alternative molecule is animal data versus remdesivir which already has phase 3 data. Sure, the other drug might be better, but it might not work at all.
And as others have mentioned, the only data for the alternative molecule is animal data versus remdesivir which already has phase 3 data. Sure, the other drug might be better, but it might not work at all.
Ben Goldacre (a Senior Clinical Research Fellow at the Centre for Evidence Based Medicine in the Department of Primary Care in the University of Oxford{0}), wrote in his book Bad Pharma, about an instance where a specific subset of SSRIs were given to eight(?) year olds for clinical depression. What the GPs prescribing them didn't know, however, was that the suicide rate for those children would go up after prescription. The pharmaceutical company knew about this. It was a negative result, and was unpublished.
This is just a single example I've pulled from the book, and the book covers only a smidgen of the hundreds of thousands of cases of incompetence and malice perpetrated by pharmaceutical companies over the last 20 years. You can find more information about this by him here ( https://www.theguardian.com/commentisfree/2008/jan/26/badsci... ), here ( https://blog.ted.com/5-prescription-drugs-doctors-had-no-ide... ), and more information in general here ( https://www.bmj.com/open-data ), and here ( https://www.livescience.com/8365-dark-side-medical-research-... )
Pharmaceutical companies' only duty is to turn a profit to their shareholders. If they spend five or ten years developing a drug that they find has either no or negative use, then in the eyes of the shareholders, they have wasted that money. The duty of the company is to find a use for the drug regardless of whether it is useful or not, regardless of whether there is a more beneficial alternative.
{0} - I copied this line, sue me :)
Disclaimer: the book mentions the institute where I'm currently employed, although the views and opinions I'm expressing are my own.
This book discusses the supply line of generic drugs on US shelves today.
If ever there has been a business decision to illustrate the whole “putting profits over people” this is it. And sunk costs, too.
This argument actually threw me for a loop. Now I'm concerned about all the other drugs that the cats didn't use first. It must be the one major missing protocol from our vastly successful drug regulation system. /s
There is not good correlation of side effects between different animals and failures in phase 1 studies often show that safety data in animals did not predict side effects in humans that became apparent in very small human populations.
So, widespread use in animals can actually harm humans by bubbling up side effects that are not relevant to humans.
Among some safety people, there is even a question of whether there are drugs shelved for animal side effects that would be 100% safe in humans. But if a drug killed half your rats, you cannot ethically start dosing humans with it.
When GS-441524 was used to treat cats with feline infectious peritonitis, a progressive and usually fatal disease caused by a coronavirus, it displayed remarkable safety and therapeutic efficacy, with 96% of cats recovering after treatment.
This is a pretty good paper that covers the issue. It wasn't that straightforward to actually get reliable data and the author here is arguing that the pendulum swung too far - adolescents weren't get antidepressants because doctors were so scared of the boxed warning the FDA added.[1]
And there is likely a bit of 20/20 hindsight going on here. Clinical trial is never black and white. You can get “signals” in the data that aren’t real, especially if the trial wasn’t powered well enough.
If we pulled drugs from the market every time someone found a signal, we’d probably have 10% of the drugs we do now, and people would be denied any benefit.
Drug development is all about risk versus benefit, and yes, the FDA is willing to approve a drug with significant risks if the drug is treating a serious disease.
[1]https://www.psychiatrictimes.com/special-reports/relationshi...
And at any rate, if Gilead choses not to develop it, then someone else can try to license it if they want to gamble on it being a good product.
Which is a neverending scandal that should outrage everyone.
It is only an appeal to authority.
Sounds like a good reason never to take either.